CN1190210C - Medical wine 'Sansan' for treating hyperosteogeny - Google Patents
Medical wine 'Sansan' for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1190210C CN1190210C CNB011404256A CN01140425A CN1190210C CN 1190210 C CN1190210 C CN 1190210C CN B011404256 A CNB011404256 A CN B011404256A CN 01140425 A CN01140425 A CN 01140425A CN 1190210 C CN1190210 C CN 1190210C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- present
- medicated wine
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to medicine for treating hyperosteogeny, which comprises Chinese angelica, safflower, frankincense, myrrh, rhizoma corydalis, leech, achyranthes root, prism tuber, notopterygium root, spicebush root and pepper. The present invention also relates to a method for preparing the medicine. The method comprises: the raw materials are mashed into coarse powder which is then infused for 5 to 10 days by 1500 to 2500 weight portions of spirit (such as Chinese spirit); dregs are removed. An effective rate reaches 100%, and a recovery rate reaches more than 96% by the certification of more than 30, 000 patients using the medicine of the present invention.
Description
Invention field
The present invention relates to a kind of Chinese patent medicine that is used for the treatment of hyperosteogeny, is a kind of Chinese medicine medicated wine for the treatment of the human body hyperosteogeny specifically.The invention still further relates to the preparation method of described medicated wine.
Background technology
Bone matrix hyperplasia is a kind of commonly encountered diseases and frequently-occurring disease, and is the highest with cervical vertebra, lumbar vertebra sickness rate especially.From clinical observation, 0-20 year person accounts for 6.25%, and 21-40 year accounts for 27%, 41-46 year accounts for 59.37%, 61-69 year accounts for 7.38%, and its sickness rate summit is 40 years old, after 35 years old, muscle, ligament, joint capsule disorder around the vertebral body are destroyed, just form hyperosteogeny, ostealleosis, osteosclerosis, Here it is the said hyperosteogeny of people, just bony spur.Change because hyperosteogeny is a kind of organic pathology, can bring the chronic disease of a series of diseases after ill, thereby be difficult to cure, and relapse rate is high.This disease still there are not effective method for treatment and specific medicament both at home and abroad at present.
Summary of the invention
The objective of the invention is to be to provide a kind of drug effect height, short treating period, taking convenience, non-evident effect, the medicated wine of the present invention that all adopts natural Chinese medicinal herb to combine can be used for treating the relevant disease that hyperosteogeny and nervus vasculairs dysfunction cause.
Medicated wine of the present invention comprise Radix Angelicae Sinensis, Flos Carthami, Olibanum, Myrrha, Rhizoma Corydalis, Hirudo,
Radix Achyranthis Bidentatae, rhizoma sparganic, Rhizoma Et Radix Notopterygii, the Radix Linderae and Fructus Piperis.Wherein the content of each raw material is (by weight):
Radix Angelicae Sinensis 20-60
Flos Carthami 20-60
Olibanum 20-60
Myrrha 20-60
Rhizoma Corydalis 20-60
Hirudo 15-45
Radix Achyranthis Bidentatae 15-45
Rhizoma sparganic 15-45
Rhizoma Et Radix Notopterygii 15-45
Radix Linderae 30-90
Fructus Piperis 10-30.
Wherein the optimum ratio of each raw material is:
Radix Angelicae Sinensis 40
Flos Carthami 40
Olibanum 40
Myrrha 40
Rhizoma Corydalis 40
Hirudo 30
Radix Achyranthis Bidentatae 30
Rhizoma sparganic 30
Rhizoma Et Radix Notopterygii 30
The Radix Linderae 60
Fructus Piperis 20.
The preparation method of medicated wine of the present invention is, smashs into above-mentioned raw materials to pieces coarser powder altogether, soaks 5-10 days with the wine (for example Chinese liquor) of 1500-2500 weight portion, and removing slag gets final product.
Certainly, also above-mentioned raw materials of the present invention can be made common formulations clinically, pill for example, powder, capsule, oral liquid, concentrated pill etc.But preferably above-mentioned raw materials being made medicated wine uses.The instructions of taking of medicated wine of the present invention is each oral 10 milliliters, and every day 2 times, one month is a course of treatment.
Medicine of the present invention has to stimulate the menstrual flow and draws network, expelling cold and dampness, sensible antiinflammatory, walk to scurry eliminating stagnation, detumescence is loose long-pending, blood circulation promoting and blood stasis dispelling, the effect of invigorating the kidney and strengthening the bones, the headache that human cervical spine hypertrophy disease is caused, migraine, dizzy, visual disorder, tinnitus, insomnia, cardiopalmus, hypertension, damping off, rear pillow part pain, neck shoulder back limb are ached symptoms such as numbness and moving obstacle, the numb flaccidity syndrome and arthralgia syndrome of the soreness of waist distending pain that the lumbar vertebra hyperosteogeny disease causes, symptoms such as waist and lower limb exercise are limited, disease curative effect the best that thoracic vertebra and other position hyperosteogeny cause.Some pathological changes disease that the neural blood vessel dysfunction is caused, as angioneurotic headache, apoplectic hemiplegia, neuralgia, vasculitis, damage, soft-tissue strain is also effective in cure, and to the wet muscle BI-syndrome involved the blood vessels resistance that causes of wind and cold, diseases such as bone joint pain have certain therapeutical effect.
Make medicated wine of the present invention and have the raw material abundance, processing technique is simple, small investment, having the general device condition can produce, and the pharmaceutical effectiveness scope is wide, suitability is strong, men and women, old and young's (careful usefulness of anemia of pregnant woman) all can use, and human body is not had obvious toxic-side effects, and are evident in efficacy, show that through contrast test short-term effect and long-term effect exceed like product.At present, routine clinical verification surplus in the of existing 30000, effective percentage reaches 100%, and cure rate is more than 96%.Follow the tracks of 570 routine patients recently, no case was recurrence, thoroughly reached the purpose of diseases such as rehabilitation hyperosteogeny and neural blood vessel dysfunction.
Specific embodiment
Embodiment 1
Radix Angelicae Sinensis, Flos Carthami, Olibanum, Myrrha, each 40 gram of Rhizoma Corydalis, Hirudo, Radix Achyranthis Bidentatae, rhizoma sparganic, each 30 gram of Rhizoma Et Radix Notopterygii, the Radix Linderae 60 grams, Fructus Piperis 20 grams are smashed into coarser powder altogether to pieces, and 2 kilograms of Chinese liquor are gone in the glass container altogether, soak to get final product in 7 days.
Embodiment 2
Radix Angelicae Sinensis, Flos Carthami, Olibanum, Myrrha, each 35 gram of Rhizoma Corydalis, Hirudo, Radix Achyranthis Bidentatae, rhizoma sparganic, each 40 gram of Rhizoma Et Radix Notopterygii, the Radix Linderae 70 grams, Fructus Piperis 20 grams are smashed into coarser powder altogether to pieces, and 2.25 kilograms of Chinese liquor are gone in the glass container altogether, soak to get final product in 7 days.
Case: the woman, 31 years old, lumbar vertebra 4-5 lip shape hypertrophy, the March of can't take care of oneself is surplus, takes the medicated wine that embodiment 1 side makes, and each oral 10 milliliters, can leave the bed in 18 days every day 2 times, recurrence was not seen in recovery from illness in three months in 11 years.
Claims (3)
1, a kind of medicated wine for the treatment of hyperosteogeny is characterized in that being made by following raw material by weight:
Radix Angelicae Sinensis 20-60
Flos Carthami 20-60
Olibanum 20-60
Myrrha 20-60
Rhizoma Corydalis 20-60
Hirudo 15-45
Radix Achyranthis Bidentatae 15-45
Rhizoma sparganic 15-45
Rhizoma Et Radix Notopterygii 15-45
Radix Linderae 30-90
Fructus Piperis 10-30.
2,, it is characterized in that the weight proportion of each raw material is according to the medicated wine of claim 1:
Radix Angelicae Sinensis 40
Flos Carthami 40
Olibanum 40
Myrrha 40
Rhizoma Corydalis 40
Hirudo 30
Radix Achyranthis Bidentatae 30
Rhizoma sparganic 30
Rhizoma Et Radix Notopterygii 30
The Radix Linderae 60
Fructus Piperis 20.
3, prepare the method for the medicated wine of claim 1 or 2, comprise and smash into described raw material to pieces coarser powder altogether, use the steeping in wine of 1500-2500 weight portion to steep 5-10 days, removing slag gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011404256A CN1190210C (en) | 2001-12-06 | 2001-12-06 | Medical wine 'Sansan' for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011404256A CN1190210C (en) | 2001-12-06 | 2001-12-06 | Medical wine 'Sansan' for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1352989A CN1352989A (en) | 2002-06-12 |
| CN1190210C true CN1190210C (en) | 2005-02-23 |
Family
ID=4675855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011404256A Expired - Fee Related CN1190210C (en) | 2001-12-06 | 2001-12-06 | Medical wine 'Sansan' for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1190210C (en) |
-
2001
- 2001-12-06 CN CNB011404256A patent/CN1190210C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1352989A (en) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972464B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
| CN1127969C (en) | Hyperosteogeny treating medicine | |
| CN1389255A (en) | Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis | |
| CN1135909A (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1190210C (en) | Medical wine 'Sansan' for treating hyperosteogeny | |
| CN101912536A (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN1181878C (en) | Detumescence plaster | |
| CN1927371A (en) | Blood flow promoting pellet and preparing process thereof | |
| CN1270053A (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1060076C (en) | Gucixiao pill for removing spur | |
| CN101057957A (en) | External applied traditional Chinese medicine lotion for treating osteoproliferation and bony spur | |
| CN1364608A (en) | Powder for curing gout | |
| CN1381250A (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN1190215C (en) | Chinese medicine for treating rheumatism | |
| CN1186084C (en) | Massage ointment for treating neck, shoulder, waist and leg pain, and extremity numbness | |
| CN1528438A (en) | External antipyretic medicinal liquor | |
| CN1166381C (en) | Medicine for curing rheumatoid arthritis, bony arthritis and rigid spinal imflammation | |
| CN103157072B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1231237C (en) | Medicine for treating hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050223 Termination date: 20100106 |